Sign in
4

Changes in Ownership

Relay Therapeutics, Inc. Filed Acc 0000950170-24-050147

Chief Financial Officer sold 1,695 shares at $6.38 ($10,814)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Catinazzo Thomas Chief Financial Officer 2024-04-29 Sale −1,695 $6.38 $10,814 339,803 D
Open-market sales · 1,695 sh · avg $6.38 · $10,814
Loading xslF345X05/ownership.xml…